DK1909782T3 - Sammensætninger omfattende arginin og R-alfa-lipoinsyrer og deres anvendelse til forbedring af sexuel funktion - Google Patents

Sammensætninger omfattende arginin og R-alfa-lipoinsyrer og deres anvendelse til forbedring af sexuel funktion

Info

Publication number: DK1909782T3
Authority: DK; Denmark
Prior art keywords: compositions; sexual function; arginine; alpha; donor
Prior art date: 2005-08-04

Application number

DK06776605.5T

Other languages

English (en)

Inventor

Klaus Wessel

Original Assignee

Encrypta Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-04

Filing date

2006-08-04

Publication date

2012-08-27

2006-08-04 Application filed by Encrypta Gmbh filed Critical Encrypta Gmbh

2012-08-27 Application granted granted Critical

2012-08-27 Publication of DK1909782T3 publication Critical patent/DK1909782T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Reproductive Health (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

DK06776605.5T 2005-08-04 2006-08-04 Sammensætninger omfattende arginin og R-alfa-lipoinsyrer og deres anvendelse til forbedring af sexuel funktion DK1909782T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP05107206A EP1754478B1 (en)	2005-08-04	2005-08-04	Liquid Composition comprising arginine and alpha-lipoic acid and its use for improvement of sexual function
PCT/EP2006/007733 WO2007017191A2 (en)	2005-08-04	2006-08-04	Compositions comprising an no donor and a dithiolane and their use for improvement of sexual function

Publications (1)

Publication Number	Publication Date
DK1909782T3 true DK1909782T3 (da)	2012-08-27

Family

ID=35502745

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK05107206T DK1754478T3 (da)	2005-08-04	2005-08-04	Flydende sammensætning omfattende arginin og alfa-liponsyre og anvendelse heraf til forbedring af den seksuelle funktion
DK06776605.5T DK1909782T3 (da)	2005-08-04	2006-08-04	Sammensætninger omfattende arginin og R-alfa-lipoinsyrer og deres anvendelse til forbedring af sexuel funktion

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK05107206T DK1754478T3 (da)	2005-08-04	2005-08-04	Flydende sammensætning omfattende arginin og alfa-liponsyre og anvendelse heraf til forbedring af den seksuelle funktion

Country Status (17)

Country	Link
US (1)	US9107889B2 (da)
EP (2)	EP1754478B1 (da)
JP (3)	JP5295766B2 (da)
CN (2)	CN102670591B (da)
AT (1)	ATE418976T1 (da)
BR (1)	BRPI0614434B8 (da)
CY (2)	CY1109430T1 (da)
DE (1)	DE602005012089D1 (da)
DK (2)	DK1754478T3 (da)
ES (2)	ES2320560T3 (da)
MX (1)	MX2008001554A (da)
PL (2)	PL1754478T3 (da)
PT (2)	PT1754478E (da)
RU (1)	RU2423120C2 (da)
SI (2)	SI1754478T1 (da)
UA (1)	UA95917C2 (da)
WO (1)	WO2007017191A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE602005012089D1 (de) *	2005-08-04	2009-02-12	Extarma Ag	Flüssige Zusammensetzung enthaltend Arginine und alpha-Liponsäure zur Verbesserung der sexuellen Funktion
FR2939042B1 (fr) *	2008-11-28	2010-11-26	Oreal	PROCEDE DE DEPIGMENTATION DES MATIERES KERATINIQUES A l'AIDE DE COMPOSES DITHIOLANNES.
RU2458537C1 (ru) *	2011-03-14	2012-08-20	Общество С Ограниченной Ответственностью "Парафарм"	Биологически активная добавка к пище для профилактики эректильной дисфункции у мужчин
FR3012039A1 (fr) *	2013-10-22	2015-04-24	Philippe Olivier Gorny	Medicament ou produit dietetique et son utilisation pour prevenir ou traiter les dysfonctionnements sexuels de l'homme et de la femme
DK180173B1 (en) *	2018-12-07	2020-07-14	Inxo Ivs	Compositions for improving sexual function
US11571405B2 (en)	2018-12-07	2023-02-07	Inxo A/S	Compositions for improving sexual function
CN109876194B (zh) *	2019-04-11	2021-04-02	湖北大学	一种可调节降解速率的poss-peg杂化水凝胶及其制备方法和其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3364822D1 (en)	1982-03-15	1986-09-04	Ici Plc	Process of oxidising hydrocarbons
DE3629116A1 (de) *	1986-08-27	1988-03-10	Asta Pharma Ag	Verfahren zur herstellung enantiomerenreiner r-(+)-(alpha)-liponsaeure und s-(-)-(alpha)-liponsaeure (thioctsaeure) sowie nonen- beziehungsweise mesylderivate als zwischenprodukte hierfuer
DE3840076A1 (de)	1987-12-04	1989-06-15	Asta Pharma Ag	Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren
DE3867445D1 (de)	1987-12-04	1992-02-13	Asta Pharma Ag	Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
EP0427247B1 (de)	1989-11-09	1998-03-11	ASTA Medica Aktiengesellschaft	Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
DE4137773A1 (de)	1991-11-16	1993-05-19	Degussa	Herstellung und verwendung von salzen der reinen enantiomere der (alpha)-liponsaeure
JP2684287B2 (ja) *	1991-12-20	1997-12-03	株式会社河合楽器製作所	楽器自動演奏装置
US5223285A (en) *	1992-03-31	1993-06-29	Abbott Laboratories	Nutritional product for pulmonary patients
DE4317646A1 (de)	1993-05-27	1994-12-01	Asta Medica Ag	Tabletten mit Thioctsäure und mindestens einer basischen Komponente
DE4433764A1 (de)	1994-09-22	1996-03-28	Asta Medica Ag	Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
US6234176B1 (en)	1996-06-21	2001-05-22	Integrated Medical Systems, Inc.	Data logger for transportable life support system
US7504376B2 (en) *	1996-08-12	2009-03-17	Natural Alternatives International	Methods and compositions for increasing the anaerobic working capacity in tissues
US6387645B1 (en)	1998-07-16	2002-05-14	Hyseq, Inc.	Methods and materials relating to novel CD39-like polypeptides
US20020068365A1 (en) *	1998-07-28	2002-06-06	Eric H. Kuhrts	Controlled release nitric oxide producing agents
US6207190B1 (en) *	1998-08-13	2001-03-27	Chronorx, Llc	Dosage forms for the treatment of the chronic glaucomas
FR2791571B1 (fr)	1999-04-02	2002-10-04	Sod Conseils Rech Applic	Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
AR042572A1 (es)	1999-04-02	2005-06-29	Sod Conseils Rech Applic	Derivados de acido lipoico, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y utilizacion de dichos derivados para la preparacion de los referidos medicamentos
ES2162586B1 (es)	1999-11-25	2002-07-01	Moraleda Manuel Gomez	Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario
US20020006907A1 (en)	2000-02-01	2002-01-17	Paul Gardiner	Alpha lipoic acid based food supplement for increasing lean muscle mass and strength
US6387945B2 (en)	2000-04-11	2002-05-14	The Regents Of The University Of California	Lipoic acid analogs
US6420342B1 (en)	2000-05-08	2002-07-16	N.V. Nutricia	Nutritional preparation comprising ribose and medical use thereof
US7128930B1 (en) *	2000-09-01	2006-10-31	Meir S. Sacks	Compositions and methods for treating sexual dysfunction
US6923960B2 (en)	2001-10-03	2005-08-02	Vsl Pharmaceuticals Inc.	Antioxidant combination composition and use thereof
ITRM20010621A1 (it)	2001-10-18	2003-04-18	Aldo Fassi	Sali metallici non igroscopici e idrosolubili di alcanoil l-carnitine, integratori dietetici che li contengono e kit dietetici, per contrast
WO2003084532A1 (en) *	2002-04-03	2003-10-16	Avery Mitchell A	Lipoic acid analogs useful as provitamins and antioxidants
NL1022153C2 (nl) *	2002-12-12	2004-06-15	Tno	Cholesterol verlagend preparaat, voedingssupplement en voedingsmiddel en werkwijzen voor de bereiding daarvan.
DE602005012089D1 (de) *	2005-08-04	2009-02-12	Extarma Ag	Flüssige Zusammensetzung enthaltend Arginine und alpha-Liponsäure zur Verbesserung der sexuellen Funktion

2005
- 2005-08-04 DE DE602005012089T patent/DE602005012089D1/de active Active
- 2005-08-04 ES ES05107206T patent/ES2320560T3/es active Active
- 2005-08-04 SI SI200530637T patent/SI1754478T1/sl unknown
- 2005-08-04 PL PL05107206T patent/PL1754478T3/pl unknown
- 2005-08-04 DK DK05107206T patent/DK1754478T3/da active
- 2005-08-04 EP EP05107206A patent/EP1754478B1/en active Active
- 2005-08-04 PT PT05107206T patent/PT1754478E/pt unknown
- 2005-08-04 AT AT05107206T patent/ATE418976T1/de active
2006
- 2006-08-04 PT PT06776605T patent/PT1909782E/pt unknown
- 2006-08-04 PL PL06776605T patent/PL1909782T3/pl unknown
- 2006-08-04 CN CN201210033057.2A patent/CN102670591B/zh active Active
- 2006-08-04 CN CN2006800289570A patent/CN101237862B/zh active Active
- 2006-08-04 UA UAA200802671A patent/UA95917C2/ru unknown
- 2006-08-04 ES ES06776605T patent/ES2388074T3/es active Active
- 2006-08-04 EP EP06776605A patent/EP1909782B1/en active Active
- 2006-08-04 DK DK06776605.5T patent/DK1909782T3/da active
- 2006-08-04 SI SI200631381T patent/SI1909782T1/sl unknown
- 2006-08-04 JP JP2008524446A patent/JP5295766B2/ja not_active Expired - Fee Related
- 2006-08-04 BR BRPI0614434A patent/BRPI0614434B8/pt active IP Right Grant
- 2006-08-04 WO PCT/EP2006/007733 patent/WO2007017191A2/en active Application Filing
- 2006-08-04 RU RU2008107877/15A patent/RU2423120C2/ru active
- 2006-08-04 MX MX2008001554A patent/MX2008001554A/es active IP Right Grant
- 2006-08-04 US US11/568,283 patent/US9107889B2/en active Active
2009
- 2009-03-18 CY CY20091100302T patent/CY1109430T1/el unknown
2012
- 2012-08-13 CY CY20121100723T patent/CY1113235T1/el unknown
2013
- 2013-02-28 JP JP2013038965A patent/JP5925714B2/ja active Active
2015
- 2015-11-30 JP JP2015233644A patent/JP2016104738A/ja active Pending

Also Published As

Publication number	Publication date
SI1754478T1 (sl)	2009-06-30
ES2388074T3 (es)	2012-10-08
PT1909782E (pt)	2012-08-16
DK1754478T3 (da)	2009-05-04
JP2009508810A (ja)	2009-03-05
EP1909782A2 (en)	2008-04-16
CN101237862A (zh)	2008-08-06
JP2013136616A (ja)	2013-07-11
DE602005012089D1 (de)	2009-02-12
ATE418976T1 (de)	2009-01-15
CY1109430T1 (el)	2014-08-13
PL1754478T3 (pl)	2009-07-31
CN101237862B (zh)	2012-03-21
WO2007017191A2 (en)	2007-02-15
MX2008001554A (es)	2008-04-22
SI1909782T1 (sl)	2012-09-28
US9107889B2 (en)	2015-08-18
BRPI0614434A2 (pt)	2011-03-29
CY1113235T1 (el)	2016-04-13
JP2016104738A (ja)	2016-06-09
RU2423120C2 (ru)	2011-07-10
WO2007017191A3 (en)	2007-05-24
CN102670591B (zh)	2014-08-06
EP1754478B1 (en)	2008-12-31
CN102670591A (zh)	2012-09-19
UA95917C2 (ru)	2011-09-26
US20080161381A1 (en)	2008-07-03
EP1909782B1 (en)	2012-05-16
JP5295766B2 (ja)	2013-09-18
BRPI0614434B8 (pt)	2021-05-25
BRPI0614434B1 (pt)	2020-04-28
JP5925714B2 (ja)	2016-05-25
ES2320560T3 (es)	2009-05-25
PL1909782T3 (pl)	2012-12-31
PT1754478E (pt)	2009-03-31
RU2008107877A (ru)	2009-09-10
EP1754478A1 (en)	2007-02-21

Publication	Publication Date	Title
DK1909782T3 (da)	2012-08-27	Sammensætninger omfattende arginin og R-alfa-lipoinsyrer og deres anvendelse til forbedring af sexuel funktion
WO2012092528A8 (en)	2012-08-09	Treatment of erectile dysfunction and other indications
BRPI0606142A2 (pt)	2009-06-02	agonistas de pyy e usos dos mesmos
WO2006099258A8 (en)	2007-10-04	Tigecycline compositions and methods of preparation
WO2007112940A3 (en)	2008-01-03	Albumin-derived amino acid sequence, use thereof for increasing the half-life of therapeutic proteins and of other therapeutic compounds and entities, and constructs comprising the same
TW200715978A (en)	2007-05-01	Highly concentrated, biocidally active compositions and aqueous mixtures and methods of making the same
DK2344130T3 (da)	2013-12-09	Farmaceutiske topiske sammensætninger
WO2006015120A3 (en)	2006-05-18	Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof
BR112012014721A2 (pt)	2017-03-14	composição de hormônio do crescimento
WO2008094563A3 (en)	2008-10-30	Use of adjuvants to improve abscisic acid performance
WO2008157304A3 (en)	2009-03-12	Stabilized thrombin compositions
IL195976A0 (en)	2009-09-01	High-strength, low-temperature stable herbicidal formulations of fluroxypyr esters
EP2455383A3 (en)	2012-09-19	4 -substituted azaadamantane derivatives and methods of use thereof
EA201000392A1 (ru)	2010-10-29	Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
WO2006089954A3 (en)	2006-12-28	Compounds for stabilizing factor vii polypeptide formulations
WO2006128802A3 (en)	2007-04-12	3-methanesulfonylquinolines as gaba-b enhancers
ATE491764T1 (de)	2011-01-15	Auto-adhäsiver klebstoff
WO2007035718A3 (en)	2009-06-18	Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8-aminocaprylic acid
ATE472316T1 (de)	2010-07-15	Haarbehandlungszusammensetzungen
WO2006113237A3 (en)	2007-01-18	Cd39l3 and its role in diabetes
MY157943A (en)	2016-08-30	Aqueous suspension concentrates
WO2008066729A3 (en)	2008-09-25	Boronic acid containing compositions
WO2009021991A9 (de)	2010-04-29	Verwendung von r(+)-alpha-liponsäure bei kryptogener neuropathie
WO2007067761A3 (en)	2007-11-29	Viscosity-reduced sprayable compositions
BR112012013723A2 (pt)	2018-01-23	"uso de pelo menos um composto de fórmula (i), método para conservar uma composição cosmética, dermatológica ou farmacêutica e composição cosmética, dermatológica ou farmacêutica"